These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [Abstract] [Full Text] [Related]
3. Review article: The medical treatment of Crohn's perianal fistulas. Schwartz DA, Herdman CR. Aliment Pharmacol Ther; 2004 May 01; 19(9):953-67. PubMed ID: 15113362 [Abstract] [Full Text] [Related]
4. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Dis Colon Rectum; 2006 Dec 01; 49(12):1837-41. PubMed ID: 17041753 [Abstract] [Full Text] [Related]
5. Management of perianal Crohn's disease. Rutgeerts P. Can J Gastroenterol; 2000 Sep 01; 14 Suppl C():7C-12C. PubMed ID: 11023554 [Abstract] [Full Text] [Related]
6. Review article: Medical therapy for fistulizing Crohn's disease. Bressler B, Sands BE. Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1283-93. PubMed ID: 17059510 [Abstract] [Full Text] [Related]
7. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab. Bouguen G, Trouilloud I, Siproudhis L, Oussalah A, Bigard MA, Bretagne JF, Peyrin-Biroulet L. Aliment Pharmacol Ther; 2009 Oct 01; 30(7):749-56. PubMed ID: 19583709 [Abstract] [Full Text] [Related]
8. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Clin Gastroenterol Hepatol; 2013 Aug 01; 11(8):975-81.e1-4. PubMed ID: 23376316 [Abstract] [Full Text] [Related]
9. Treatment of fistulizing Crohn's disease. Judge TA, Lichtenstein GR. Gastroenterol Clin North Am; 2004 Jun 01; 33(2):421-54, xi-xii. PubMed ID: 15177547 [Abstract] [Full Text] [Related]
10. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P. Am J Gastroenterol; 2003 Feb 01; 98(2):332-9. PubMed ID: 12591051 [Abstract] [Full Text] [Related]
11. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q, Hogezand RA, Lamers CB, Verspaget HW. Aliment Pharmacol Ther; 2004 Sep 01; 20(5):585-92. PubMed ID: 15339330 [Abstract] [Full Text] [Related]
12. Perianal fistulizing Crohn's disease: a call to action. Kamm MA, Ng SC. Clin Gastroenterol Hepatol; 2008 Jan 01; 6(1):7-10. PubMed ID: 18063415 [Abstract] [Full Text] [Related]
13. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease. Cat H, Sophani I, Lemann M, Modiglani R, Solue JC. Turk J Gastroenterol; 2003 Jun 01; 14(2):121-7. PubMed ID: 14614639 [Abstract] [Full Text] [Related]
14. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M. Digestion; 2008 Jun 01; 78(4):195-200. PubMed ID: 19122456 [Abstract] [Full Text] [Related]
15. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P, Van Assche G. Clin Gastroenterol Hepatol; 2011 Feb 01; 9(2):130-6. PubMed ID: 21056696 [Abstract] [Full Text] [Related]
16. Local injection of Infliximab for the treatment of perianal Crohn's disease. Poggioli G, Laureti S, Pierangeli F, Rizzello F, Ugolini F, Gionchetti P, Campieri M. Dis Colon Rectum; 2005 Apr 01; 48(4):768-74. PubMed ID: 15768185 [Abstract] [Full Text] [Related]
18. The patient with persistent perianal fistulae. Koutroubakis IE. Best Pract Res Clin Gastroenterol; 2007 Apr 01; 21(3):503-18. PubMed ID: 17544114 [Abstract] [Full Text] [Related]
19. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG, van Gemert WG. Dis Colon Rectum; 2005 Apr 01; 48(4):758-67. PubMed ID: 15750797 [Abstract] [Full Text] [Related]
20. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP. Dis Colon Rectum; 2007 Nov 01; 50(11):1754-60. PubMed ID: 17899271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]